arrow
Return

Journal

Lancet Infectious Diseases cover
Lancet Infectious Diseases
IF:
31
Papers:
8.0K
Citations:
4.0W

Organization

B
baylor college of medicine
Scholars:
4.7K
Papers: 1.7K
Citations: 0
Cited Papers

Cited Papers

The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness
err2025-08-01
err0
PREAI
errAshraf,Mansoor; Stein,Alicia N.; Youhanna,John; Rockman,Steven; McMahon,Meagan; McGovern,Ian; Rajaram,Sankarasubramanian; Miller,Matthew S.
errShare
errSave
errShare
errSave
Immunogenicity and safety of higher-dose cell-based adjuvanted quadrivalent influenza vaccines: Combined results of randomised, controlled dose-finding and dose-confirmation studies
errVaccine
IF3.5
err2026-03-19
err0
errOAAI
errFred de Looze; Brandon J. Essink; Josephine van Boxmeer; Coralie Andrade; Richard de Rooij; Daniela Casula; Ruoyu Xing; Maria Piedrahita Tovar; Frank R. Albano
errShare
errSave
Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis
err2023-10-17
err10
errOAAI
errColeman, Brenda L.; Gutmanis, Iris; Mcgovern, Ian; Haag, Mendel
errShare
errSave
Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact
err2024-12-01
err0
errOAAI
errJessica Taaffe; Julia T. Ostrowsky; Joshua Mott; Shoshanna Goldin; Martin Friede; Pierre Gsell; Christopher Chadwick
errShare
errSave
Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis
err2024-09-04
err5
errOAAI
errFerdinands, J. M.; Blanton, L. H.; Alyanak, E.; Chung, J. R.; Trujillo, L.; Taliano, J.; Morgan, R. L.; Fry, A. M.; Grohskopf, L. A.
errShare
errSave
Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults
err
err0
PREAI
errHsiao,Amber; Leong,Thomas; Fireman,Bruce; Hansen,John; Zerbo,Ousseny; Jacobson,Karen B.; Liao,Lauren D.; Haag,Mendel D. M.; McGovern,Ian; Zhang,Bin; Dang,Juliet; Klein,Nicola P.
errShare
errSave
Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017–2018
err2020-03-01
err0
errOAAI
errEdward A. Belongia; Min Z. Levine; Oluwatosin Olaiya; F. Liaini Gross; Jennifer P. King; Brendan Flannery; Huong Q. McLean
errShare
errSave
no more